Track topics on Twitter Track topics that are important to you
Advisers to the US regulator will meet today to discuss Spark Therapeutics' Luxturna, which could become the first gene therapy approved for an inherited disease in the US. However concerns about the treatment's safety and efficacy have been raise...
Original Article: FDA experts to vote on Spark's groundbreaking gene therapyNEXT ARTICLE
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...